{"OspA lipoprotein":{"RelatedTo":"B-cell receptor CD22","Synonym":["Outer surface protein A precursor"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB00045","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB00045","Definition":"Vaccine against Lyme disease that contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. It is conjugated with alum (aluminum hydroxide) as an adjuvant. Pharmacology: OspA lipoprotein is a single polypeptide chain of 270 amino acids. It is a vaccination used to prevent Lyme Disease. Mechanism of action: OspA lipoprotein, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, is used to stimulate the production of specific antibodies against B. burgdorferi. B. burgdorferi. Therefore, it is used as a vaccination against Lyme Disease.s Drug type: Approved. Biotech. Drug category: Vaccines"}}